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Type 2 diabetes mellitus (T2DM) adversely affects the normal functioning, intrinsic material
properties, and structural integrity of many tissues, including bone. It is well known that the
clinical utility of areal bone mineral density (aBMD) is limited to assess bone strength in individuals with T2DM. Therefore, there is a need to explore new diagnostic techniques that can
better assist and improve the accuracy of assessment of bone tissue quality. The present
study investigated the link between bone and fingernail material/compositional properties in
type 2 diabetes mellitus (T2DM). For that, femoral head and fingernail samples were
obtained from twenty-five adult female patients (with/without T2DM) with fragility femoral
neck fractures undergoing hemi/total hip arthroplasty. Cylindrical cores of trabecular bone
were subjected to micro-CT, and lower bone volume fraction was observed in the diabetic
group than the non-diabetic group due to fewer and thinner trabeculae in individuals with
T2DM. The material and compositional properties of bone/fingernail were estimated using
nanoindentation and Fourier Transform Infrared Spectroscopy, respectively. Both bone/fingernails in T2DM had lower reduced modulus (Er), hardness (H), lower Amide I and Amide II
area ratio (protein content), higher sugar-to-matrix ratio, and relatively high carboxymethyllysine (CML) content compared with non-diabetic patients. Sugar-to-matrix ratio and relative
CML content were strongly and positively correlated with HbA1c for both bone/fingernail.
There was a positive correlation between bone and fingernail glycation content. Our findings
provide evidence that the degradation pattern of bone and fingernail properties go hand-inhand in individuals with T2DM. Hence, the fingernail compositional/material properties
might serve as a non-invasive surrogate marker of bone quality in T2DM; however, further
large-scale studies need to be undertaken.
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Fingernail as surrogate marker of bone quality in diabetes

Introduction
Type 2 diabetes mellitus (T2DM) affects bone homeostasis and quality, resulting in a threefold increased risk of fragility fracture depending on the skeletal site and glycemic burden [1–
5]. The disease burden is expected to increase further in the near future [6]. Therefore, early
identification of bone disease and timely implementation of specific therapies can help prevent
incident fragility fractures and subsequently reduce the substantial socioeconomic burden,
morbidity and mortality.
At present, the measurement of areal bone mineral density (aBMD) is the standard
approach to estimate bone health. However, aBMD is often normal or even slightly elevated in
patients with T2DM compared to age- and sex-matched controls, hence, aBMD alone underestimates fracture risk in T2DM [7,8]. Thus, mineral quantification alone, as represented by
aBMD, is not sufficient, and the study of bone matrix (collagen) characteristics is equally
important to predict future fracture risk [2,9–14]. Besides, bone histomorphometry is the gold
standard to assess the bone quantity and quality [15,16], however, trans-iliac bone biopsy is an
invasive procedure, requires expertise, and may not always be feasible to perform in routine
clinical practice. Additionally, bone biopsy involves the risk of infection or delayed healing,
particularly in individuals with uncontrolled hyperglycemia. Therefore, there is a need to
develop newer techniques that can better assist and improve the accuracy of assessment of
bone health in diabetes mellitus.
Our previous study have shown that the microstructural and macromolecular characteristics of fingernails are degraded in patients with T2DM [17]. Accordingly, we have hypothesized that the fingernail plate has the potential to serve as a potential surrogate marker to
predict bone damage in diabetes because of the following reason: (i) The major constituent of
fingernail plate (Keratin, present in ±85%) is also prone to glycation [17–20]. (ii) The growth
of the nail plate is relatively slow; hence the long-term effects of hyperglycemia can reflect on
the fingernail material and compositional properties [17,21]. (iii) Rate of fingernail growth
and the bone cycle is 90–120 days, making it an ideal tissue to study. (iv) Study on fingernails
is painless, non-invasive, and economical because they neither requires specific storage nor do
they demand the use of expensive reagents [17–20].
Thus, the present study aims to investigate the link between bone and fingernail material/
compositional properties in patients with T2DM. Herein, we have measured the microstructural properties (high-resolution μCT), material properties (reduced modulus and hardness),
and compositional properties (relative content of glycation, normalized area of amide I and
amide II) of both bone and fingernail.

Research design and methods
Study participants
Consecutive postmenopausal women admitted with femoral neck fragility fractures in the
Department of Orthopedics, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India, undergoing hemi/total hip arthroplasty between July 2016 and July
2019 were recruited. All participants involved in the study were from Northern India. Patients
with a prior history of fracture, having onychomycosis, on anti-osteoporotic medications, glucocorticoid, thiazides, or calcium/vitamin D supplements (over the last 6 months) were
excluded. All patients underwent assessment of aBMD of the contralateral femoral neck using
dual-energy X-ray absorptiometry (HOLOGIC Discovery A QDR 4500, Hologic Inc., Bedford,
MA, USA). The study protocol was approved by the Institutional Ethics Committee, PGIMER,
Chandigarh (Approval Number PGI/IEC/2015/171). Prior written informed consent was
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obtained from all the participants that their discarded bone, clipped fingernail and clinical
data will be used for scientific work. After exclusion, a total of 50 patients with included of
whom 25 had T2DM while the rest 25 did not have diabetes mellitus. Later, all experiments
were performed in Indian Institute of Technology Ropar.

Sample procurement and storage
Excised femoral heads were collected from patients undergoing hemi/total hip arthroplasty.
The cylindrical trabecular bone cores were extracted from each femoral head along the direction of the principal trabeculae using a drilling machine attached with a diamond core bit. The
bone cores were cleaned with water jet, wrapped in saline-soaked gauze (PBS 7.4 pH), transferred into sample bags, labeled, and subsequently stored at -20˚C [14]. Along with the femoral
head, the fingernail plate samples were also collected from the distal part of the right-hand
middle finger using a nail clipper. Collected fingernail samples were sectioned into 2–3 small
pieces so that they can be subsequently utilized for different characterization techniques [17].
All experiments were conducted within two months of sample collection. Experimental studies
were performed in the Indian Institute of Technology (IIT), Ropar.

Assessment of bone quality parameters
Microstructural parameters by μ-CT. One bone core of each patient was air-dried and
scanned along the cylindrical axis using a high-resolution μCT system (GE Sensing & Inspection Technologies GmbH-phoenix|x-ray using 10 μm voxel size, 45 keV tube voltage, 250 μA
beam current, 250 sec integration time, 10 frames). Reconstruction of scanned images was performed using Phoenix software (phoenix/x-ray, GE Measurement & Control; Germany), and
reconstructed images were imported in Scan-IP (Simpleware Ltd, UK) for the analysis of the
following structural parameters: bone volume fraction (BV/TV), trabecular thickness (Tb.Th),
and trabecular number (Tb.N) were calculated as per published protocol [14].
Fingernail and bone material properties by nanoindentation. Nanoindentation tests
were performed on both bone and fingernail samples using a TI-950 Tribo Indenter (Hysitron
Inc., Minneapolis, MN, USA) with Berkovich pyramidal tip (tip radius ~150 nm). Before testing, the samples were embedded in epoxy and polished. Locations for indents were identified
using an in-situ scanning probe microscope imaging integrated with a nanoindentation system, and all tests were performed at room temperature in a moist condition. Experiments
were conducted as per the previously published protocol [14,17].
Eight indents with a peak load of 1000 μN were applied on the surface of the samples. A
load function consisting of a ten-second ramp to peak force segment was adopted, followed by
a thirty-second hold and a ten-second unloading segment [17]. The load-displacement curves
obtained in these indentation tests were analyzed to determine the reduced modulus (Er) and
hardness (H) using Oliver and Pharr method in Triboscan (Hysitron) [22,23].
Collagen and keratin properties by Fourier Transform Infrared Spectroscopy (FTIR).
The trabecular bone was demineralized using a 9.5% ethylene diamine tetra-acetic acid
(EDTA) solution in phosphate-buffered saline. The tissue was submerged in the EDTA solution for five days at 4˚C; the solution was changed every 24 hours. After five days, the demineralized tissue was rinsed twice with acetone for 10 minutes and then rinsed twice with
deionized water for 10 minutes [24]. Then, FTIR spectra were recorded from the freeze-dried
fingernail and demineralized bone section using FTIR Spectrometer in Attenuated Total
Reflectance (ATR) mode (Nicolet iS50, Thermo Scientific, Inc. Waltham, MA, USA) under
constant pressure, in the spectral region of 4000 to 400 cm–1. One sample of both bone and fingernail is tested of each donor with 4 μm resolution, and 60 scans were averaged. The
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Fig 1. A Representative FTIR spectra of the human fingernail and trabecular bone (demineralized) showing the position of amide
I, Amide II, CML, sugar, and methylene (CH2) deformation band vibrations for the non-diabetic and diabetic groups, B showing
Raman and FTIR spectra of a CML reference standard.
https://doi.org/10.1371/journal.pone.0257955.g001

representative FTIR spectra of bone and fingernail with the appropriate label of various bands
are shown in Fig 1A. The following parameters were calculated: the mean integrated area ratio
(relative content) of amide I (protein C = O stretching, 1600–1700 cm−1) and Amide II (protein N–H bending, C–N stretching, 1500–1600 cm−1) bands with respect to methylene (CH2)
deformation band at 1450 cm–1 [14,17,25,26].
The mean integrated area ratio (relative content) of sugar-to-matrix ratio [area of the sugar
peak [(ν CO and ν CC peaks) (900–1100 cm-1) to amide I peak (1596–1712 cm-1)] was calculated as per published protocol [24].
The mean integrated area ratio (relative content) of 1150 cm−1 (carboxymethyl-lysine,
CML)/1450 cm−1 was also calculated. Relative CML content has previously been validated
with Raman spectroscopy [27,28], where CML is a lysine derivative and lysine reference has
a significant Raman band at ~1150 cm-1 [27,29]. Here, we have validated the presence of
CML peak by both Raman and FTIR spectroscopies. For reference, both Raman and FTIR
spectra of a CML standard (Cayman chemical company, Michigan, USA) have been
included in Fig 1B.
Statistical analysis. The normality of the data was checked using the Kolmogorov-Smirnov test. Data were expressed as mean and standard deviation (SD) until otherwise specified.
The homogeneity of variances was analyzed using the Levene’s test. Between-group differences
of calculated parameters were analyzed for statistical significance using Student’s t-tests after
testing for normality and homogeneity of variances. Pearson correlation and linear regression
tests were used to determine relationships between structural, material, and compositional
parameters. Observed power is calculated by comparing the mean value of sugar-to-matrix
ratio in bone/fingernail between diabetic and non-diabetic groups using an ANOVA test. A
confidence level of p < 0.05 implies a statistical significance between the groups where p<0.05,
p<0.01, and p<0.001 denote the significance level.
Statistical analysis was performed using the Statistical Package for the Social Sciences (v.21,
SPSS Inc., Chicago, IL, USA) and the Microsoft Office Excel (2007).
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Table 1. Baseline demographic and radiographic parameters of women with and without T2DM included in the present study.
Parameters

Women without T2DM (N = 25)

Women with T2DM (N = 25)

Age (years)

74.1 ± 7.8

72.2 ± 8.7

0.701

HbA1c (%)

5.5 ± 0.6

7.8 ± 1.3

0.001

na

7.0 ± 2.2

na

Femoral Neck aBMD (gm/cm )

0.549 ± 0.079

0.487 ± 0.119

0.353

Femoral Neck T score

-2.8 ± 0.87

-2.9 ± 0.83

0.749

Duration of diabetes (years)
2

p-value

All data are expressed as mean ± SD, na: not applicable; HbA1c: glycosylated hemoglobin A1c; FN: Femoral neck; aBMD: areal bone mineral density.
p<0.05, �� p<0.01 and ��� p<0.001 respectively compared to non-diabetic group.

�

https://doi.org/10.1371/journal.pone.0257955.t001

Results
Patient’s characteristics
Over the study period, a total of 86 postmenopausal women with femoral neck fragility fractures were admitted in the Department of Orthopedics and underwent hemi/total hip arthroplasty. Out of these 86 women, 36 patients were excluded (18 had a recent history of calcium/
vitamin D intake, 10 had a history of intake of anti-osteoporotic medications along with a
recent history of calcium/vitamin D use, 5 had a prior history of fragility fractures, 3 did not
provide written informed consent). Finally, 50 patients were included in the study. Out of
these 50 patients, 25 patients had T2DM (mean age 74.1±7.8 years) and the rest 25 patients did
not have T2DM (mean age 72.2±8.7 years). The mean duration of T2DM was 7.0±2.2 years;
the mean HbA1c was 7.8±1.3%. There was no significant difference in age (p = 0.701) or contralateral femoral neck aBMD (p = 0.353) between the two groups (Table 1).

Structural parameters (μ-CT)
Representative μCT images and mean values of microstructural parameters of diabetic and
non-diabetic groups are shown in Fig 2. The diabetic bone had significantly lower (mean) values of BV/TV (17.0±4.4 vs. 22.1±6.1, p = 0.009), Tb.Th (0.146±0.03 vs. 0.166±0.03, p = 0.028)

Fig 2. Measures of bone microstructural parameters for diabetic and non-diabetic trabecular bone, showing lower
BV/TV (%) (A), Tb.Tb (mm) (B) and Tb.N (1/mm) (C) in diabetic group.
https://doi.org/10.1371/journal.pone.0257955.g002
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and Tb.N (1.15±0.13 vs. 1.26±0.25, p = 0.032) than the non-diabetic group. The diabetic
group had significantly lower BV/TV (23.07%), Tb.Th (12.0%), and Tb.N (8.73%) compared
to the non-diabetic group.

Collagen and keratin properties and measurement of glycation
The bone of diabetic individuals had significantly higher sugar/matrix ratio (0.33±0.07 vs. 0.25
±0.04, p<0.001) and relative content of CML (AGE) (0.74±0.32 vs. 0.54±0.27, p = 0.019) compared to non-diabetic individuals (Fig 3A). Likewise, the diabetic fingernail had significantly
higher sugar/matrix ratio (0.30±0.10 vs. 0.18±0.07, p<0.001) and relative content of CML
(AGE) (0.40±0.12 vs. 0.32±0.14, p = 0.037) compared to the non-diabetic group (Fig 3B).
Also, the diabetic bone had a lower value of area under the normalized peak of Amide I and
Amide II bands (3.67±2.08 vs. 7.36±3.93, p<0.001 and 1.22±0.91 vs. 2.93±1.49, p<0.001,
respectively), compared to the non-diabetic group (Fig 4A). These results indicate that the
quantity of these proteins is lower in the diabetic bone. Similarly, Fig 4B shows that the diabetic fingernail also had a lower value of area under the normalized peak of Amide I and
Amide II bands (10.50±2.39 vs. 15.33±5.88, p = 0.009 and 8.09±1.76 vs. 10.90±3.06, p = 0.026,
respectively), compared to the non-diabetic group. These results also indicate that the quantity
of these proteins is lower in the diabetic fingernail.

Material properties
Nanoindentation tests for both the groups revealed that under the same load of 1000 μN, the
diabetic bone had significantly lower (mean) values of reduced modulus (7.38±2.96 GPa vs.
9.13±2.58 GPa, p = 0.022) and hardness (0.268±0.16 GPa vs. 0.441±0.25 GPa, p = 0.004) than
the non-diabetic group (Fig 5A). The modulus and hardness were lower by 19.17% and
39.23%, respectively, in the diabetic group compared to the non-diabetic group.

Fig 3. Sugar-to-matrix ratio and normalized CML content obtained from FTIR, showing higher mean values in
diabetic group for both bone (A) and fingernail (B) respectively.
https://doi.org/10.1371/journal.pone.0257955.g003
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Fig 4. Normalized Amide I and Amide II area obtained from FTIR, showing lower mean values in diabetic group for
both bone (A) and fingernail (B) respectively.
https://doi.org/10.1371/journal.pone.0257955.g004

Fig 5. Reduced modulus and hardness obtained from nanoindentation, showing lower mean values in diabetic group
for both bone (A) and fingernail (B) respectively.
https://doi.org/10.1371/journal.pone.0257955.g005
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With the same loading condition, the diabetic fingernail also had significantly lower
(mean) values of reduced modulus (4.00±0.56 GPa to 4.60±0.98 GPa, p = 0.026) and hardness
(0.152±0.04 GPa to 0.212±0.06 GPa, p = 0.003) than the non-diabetic group (Fig 5B). The
reduced modulus and hardness were lower by 13.04% and 28.3%, respectively, in the diabetic
fingernails compared to the non-diabetic subjects.

Interrelationships between variables
In the diabetic group, the pre-operative HbA1c was positively correlated with the sugar-tomatrix ratio in bone (r = 0.654, p<0.001) and fingernail (r = 0.527, p = 0.007), as shown in Fig
6A and 6B, respectively.
Linear regression analyses with bone glycation as a dependent variable and fingernail glycation as an independent variable showed that in the diabetic group, the fingernail sugar-tomatrix ratio can explain up to 20% (r = 0.45, p = 0.025, β = 0.291) of variance in the sugar-tomatrix ratio in bone, and relative CML content of fingernail can explain up to 29% (r = 0.54,
p = 0.005, β = 1.494) of variance in relative CML content in bone (Fig 7A and 7B, respectively). Also, the variance in reduced modulus of bone and microstructural parameter BV/TV
can be explained by up to 23% (r = 0.48, p = 0.015, β = 2.937) and 21% (r = 0.46, p = 0.020, β =
5.477) (Fig 7C and 7D), respectively by the reduced modulus of fingernail in the diabetic
group. In the non-diabetic group, none of the parameters were found to be significant.
We performed the observed power of the study by comparing the mean value of the sugarto-matrix ratio in fingernail/bone between diabetic and non-diabetic groups, and this outcome
was found to be 99.9% for both tissues.

Discussion
The present study, which, to the best of our knowledge, happens to be the first of its kind,
shows that the microstructural and material properties are altered in the bone of patients with
T2DM, which go hand-in-hand with the fingernail plate compositional/material properties.
We found significant correlations between the two body tissues, possibly suggesting that fingernails properties might serve as a potential surrogate marker of underlying bone quality in
patients with T2DM.
In a prior study on an animal model, through the concurrent assessment of mechanical,
microstructural, and compositional properties of bone, we had reported that T2DM alters the

Fig 6. Correlation between HbA1c and the sugar-to-matrix ratio for both bone and fingernail are shown in 6(A) and 6
(B) respectively for diabetic and non-diabetics groups.
https://doi.org/10.1371/journal.pone.0257955.g006
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Fig 7. Correlation between fingernail and bone for diabetic patients and non-diabetics (A) for sugar-to-matrix ratio,
(B) for relative CML content, (C) for nanoindentation determined reduced modulus, (D) BV/TV of trabecular bone
and fingernail reduced modulus.
https://doi.org/10.1371/journal.pone.0257955.g007

cortical bone quality making the bone weaker and prone to fragility fractures. The presence of
T2DM reduces whole bone strength, compromises structural properties (μCT), and increases
AGEs [30]. In another study on individuals with T2DM and known fragility fracture, we have
shown that diabetes adversely affects the trabecular bone quality at multiple organization levels. The accumulation of AGEs favors the deterioration of bone quality in diabetes, leading to
altered structural, material, and compositional properties. All these changes culminate in
reduced bone elasticity and toughness with a corresponding increase in the propensity to bone
fragility [14].
On the other hand, T2DM also exerts an adverse effect on the human fingernail plate quality. Hence, there could be an association in the degradation pattern of both the tissues. Indeed,
the fingernail is composed predominantly of keratin which is prone to glycation just as collagen in bone. In addition, the fingernail’s growth is slow, allowing time for hyperglycemia to
exert its detrimental effect [17]. Carrying forward this hypothesis, in the present study, we
found marked differences in compositional/material properties of bone and fingernail in
patients with and without T2DM.
Here, the assessment of bone microstructure on micro-CT showed lower BV/TV (%) in
those with diabetic group compared to the non-diabetic group. The bone microstructure was
noticeably altered, evidenced by the thinning of trabeculae and by fewer trabecular numbers.
However, few recent studies [24,31–33] obtained the same or increased BV/TV in those with
diabetes compared to non-diabetics. Notably, in these studies [24,31–33], the bone tissues
were obtained from individuals with obesity and/or severe arthritis, which possibly could
explain the difference in the findings of BV/TV from this study. In contrast, the previous study
published from our institution reported lower BV/TV in individuals with T2DM and fragility
fractures [14]. It is also possible that our study finding of lower BV/TV in diabetes is related to
the distinct phenotypes of Asians [30,34–38].
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At the material level, a lower value of reduced modulus and hardness is observed in those
with diabetes than in the non-diabetic group. Thus, this finding describes that long-standing
T2DM alters bone microstructure and material properties and makes the bone weaker and
fracture prone. These results also revealed that the above alteration in the properties locally,
either at micro-scale or nano-scale, can affect the properties of the hierarchical organization of
bone at higher scales [39,40].
In compositional analysis, we observed that the FTIR signatures and spectral changes of
bone collagen and nail keratin are comparable and can discriminate the samples of the diabetic
and non-diabetic groups. We found significantly increased glycation content (relative CML
content and sugar-to-matrix ratio) in the diabetic group of both bone and fingernail compared
to the non-diabetic group. Along with the increased glycation content, the decreased relative
proteins content (Amide I/1450 cm-1 and Amide II/1450 cm-1) is observed in the diabetic
groups for both bone and fingernail compared to the non-diabetic group. These results are
consistent with the previous studies that reported the decreased total protein content in diabetic rat skeletal soleus muscles [25] and reduced Amide content in diabetic fingernails [17].
Furthermore, the HbA1c was significantly and positively correlated with the sugar-tomatrix ratio for both bone and fingernail, implying that the primary reason for the degradation
of bone and fingernail quality in T2DM is prolonged hyperglycemia. Hyperglycemia, in turn,
predisposes to the accumulation of AGEs in the bone and nail matrix and induces tissue damage through structural modification of proteins and abnormal proteins collagen fibril organization in diabetes [41]. Also, abnormal glycation decreases the osteogenic differentiation and
activity [42,43], which results in reduced overall protein synthesis (decreased Amide I, Amide
II content) and decreased material properties of both bone and fingernail at nano-scale, and
lower bone formation (BV/TV) at micro-scale.
Usually, severe complications such as fracture or tearing are not observed in the diabetic
nail. This is because the accumulation of AGE varies in the fingernail as it grows and gets
entirely replaced within a few months, whereas the complete removal of accumulated AGEs
from diabetic bone is not possible, and thus it causes severe damage and leads to bone fracture
[17]. The present study revealed that in postmenopausal women with T2DM, the material and
compositional properties of fingernails are degraded to a similar extent as is seen in the bones.
The marked correlation observed for measures of glycation between fingernail and bone in the
diabetic group confirms the role of fingernail in the prediction of bone glycation. Also, the
reduced modulus of the fingernail was found to correlate with the reduced modulus of bone
and BV/TV in the diabetic group, suggesting that the degraded fingernail material property is
associated with the degraded bone material property and altered bone microstructure. Therefore, investigating fingernail properties can be a non-invasive solution to gauge about the status of bone health and the prediction of fracture risk in patients with diabetes mellitus.
We humbly acknowledge the study limitations. First, the sample size was limited to only 50
participants. Nevertheless, the index study was meant to be a pilot study. Second, we had
included only postmenopausal women so as to ensure a homogenous study population. Inclusion of men and premenopausal women would have created multiple heterogeneous subgroups which would have compromised our statistical validity. Third, the collection of bone
samples from the femoral head rather than the conventional trans-iliac bone biopsy. However,
there exists a weak association between the histomorphometric parameters of the iliac crest
and proximal femur. Hence, femoral head samples may be clinically more relevant in hip fractures [44].
In conclusion, the present pilot study shows that the microstructural and material properties are altered in the bone of patients with T2DM, which go hand-in-hand with the fingernail
plate compositional/material properties. Accordingly, fingernails properties might serve as a
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potential surrogate non-invasive marker of underlying bone quality in patients with T2DM.
Early detection of impaired bone health in patients with T2DM would help timely implement
bone-directed therapies that would avert incident fragility fractures. However, the findings
need to be validated in further large-scale studies involving a substantial number of patients of
both sexes with varying duration of diabetes and glycemic control.
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